Exhibit 10.1
NOTE AND WARRANT PURCHASE
AGREEMENT
THIS NOTE AND WARRANT PURCHASE
AGREEMENT (this “Agreement”) is made as of
February 27, 2009 by and among InnerCool Therapies, Inc., a
Delaware corporation (“InnerCool”), Tissue Repair
Company, a Delaware corporation (“TRC”) and Cardium
Therapeutics, Inc., a Delaware corporation (“Cardium”
or the “Company” and, together with InnerCool and TRC,
individually, a “Borrower,” and collectively, the
“Borrowers”), and the investors listed on
Schedule A hereto, each of which is herein referred to
as an “Investor.”
THE PARTIES HEREBY AGREE AS
FOLLOWS:
SECTION 1
ISSUANCE OF NOTES AND
WARRANTS
1.1 Issuance of Notes .
Subject to the terms and conditions of this Agreement, at each
Closing (as defined below), the Borrowers shall issue and sell to
each Investor participating in such Closing a senior subordinated
secured promissory note (each such note, a “Note” and
collectively, the “Notes”) in the principal amount (the
“Principal Amount”) equal to the amount set forth below
Investor’s name on the signature page of this Agreement and
on Schedule A attached hereto, against payment by such
Investor to the Company of the Principal Amount. The Notes shall
each be in the form of Exhibit A attached hereto and
shall be subordinate to the Senior Notes (as defined in
Section 2.3(b) below) in accordance with Section 7
thereof. Capitalized but otherwise undefined terms used herein
shall have the meanings provided therefor in the Notes.
1.2 Issuance of Warrants .
Subject to the terms and conditions of this Agreement, at each
Closing, the Company shall issue to each Investor that has
purchased a Note hereunder, with respect to each such Note, a
warrant (the “Warrants”), in the form of
Exhibit B attached hereto, representing the right to
purchase up to that number of shares of Common Stock of the Company
(the “Warrant Shares”) (as adjusted for stock splits,
recapitalizations or other similar events) calculated as
follows:
|
|
|
|
|
|
number of shares of Common
Stock issuable upon
exercise
of the Warrant
|
|
=
|
|
Principal Amount of Note x .43
|
The Warrants shall, unless sooner
terminated as provided therein, have a term of five years from the
date of issuance and shall be exercisable at an exercise price
(subject to adjustment as set forth in the Warrants) equal to the
Stock Purchase Price.
1.3 Stock Purchase Price .
For purposes of this Agreement, “Stock Purchase Price”
shall mean $2.00 per share.
1
SECTION 2
CLOSINGS
2.1 Initial Closing . The
initial closing of the purchase and sale of Notes hereunder (the
“Initial Closing”) shall be held at the offices of
Bell, Boyd & Lloyd, LLP, 3580 Carmel Mountain Road, Suite
200, San Diego, California or remotely by facsimile transmission or
other electronic means, on the date of this Agreement.
Notwithstanding anything to the contrary in this Agreement, a
minimum of $2,500,000 principal amount of Notes must be issued and
sold at the Initial Closing.
2.2 Subsequent Closings . The
Borrowers may issue and sell Notes in the aggregate principal
amount of up to $3,500,000 hereunder. Subsequent to the Initial
Closing and subject to the foregoing limitation, the Borrowers may
issue and sell additional Notes to such additional investors as
they shall select in their sole and absolute discretion. Any such
additional investor shall execute and deliver a counterpart
signature page to this Agreement, and thereby become a party to and
be deemed an Investor hereunder. All additional Investors and all
additional Principal Amounts invested hereunder shall be reflected
on Schedule A , which shall be automatically amended
without any further action by any party hereto. The closing of the
purchase and sale of such additional Notes hereunder shall be held
at the offices of Bell, Boyd & Lloyd, LLP, 3580 Carmel
Mountain Road, Suite 200, San Diego, California or remotely by
facsimile transmission or other electronic means; provided that
such closing occurs on or before March 31, 2009 (which
closing, together with the Initial Closing, are designated as a
“Closing”).
2.3 Conditions . The several
obligations of the Investors to purchase the Notes on the date of
the Initial Closing shall be subject to the prior or concurrent
satisfaction of each of the conditions precedent set forth in this
Section 2.3 .
(a) Representations and
Warranties Correct; Performance of Obligations . The
representations and warranties made by each Borrower contained
herein shall be true and correct in all material respects (except
for those representations and warranties which are qualified as to
materiality, in which case such representations and warranties
shall be true and correct in all respects), and each Borrower shall
have performed, satisfied and complied with all covenants,
agreements and conditions herein required to be performed,
satisfied or complied with by it at or prior to the
Closing.
(b) Consents and Waivers .
Each Borrower shall have obtained any and all consents (including
all governmental or regulatory consents, approvals or
authorizations required in connection with the valid execution and
delivery of this Agreement), permits and waivers necessary or
appropriate for consummation of the transactions contemplated by
this Agreement, including but not limited to the consent of the
holders of a majority of the aggregate principal amount of
outstanding Senior Secured Promissory Notes of the Company dated
November 5, 2008 and November 10, 2008 (the “Senior
Notes”) issued pursuant to that certain Note and Warrant
Purchase Agreement dated November 5, 2008 (the “Senior
Note Purchase Agreement”) among the Borrowers and the lenders
named therein (the “Senior Lenders”) to the granting to
the Lenders of a security interest pursuant to the Security
Agreement.
2
(c) Judgments . No judgment,
writ, order, injunction, award or decree of or by any court, or
judge, justice or magistrate, including any bankruptcy court or
judge, or any order of or by any governmental authority, shall have
been issued, and no action or proceeding shall have been instituted
by any governmental authority, enjoining or preventing the
consummation of the transactions contemplated in this
Agreement.
(d) Stop Orders . No stop
order or suspension of trading shall have been imposed by the SEC
or any other governmental or regulatory body with respect to public
trading in the Company’s Common Stock.
(e) CEO/CFO Certificate .
Each Borrower shall have delivered a Certificate, executed on
behalf of each Borrower by its Chief Executive Officer or its Chief
Financial Officer, dated as of the Closing Date, certifying to the
fulfillment of the conditions specified in subsections (a), (b),
(c) and (d) above. This item shall be applicable for all
Subsequent Closings as well.
(f) Opinion of Borrowers’
Counsel . Investor shall have received from Bell,
Boyd & Lloyd, LLP, counsel to the Borrowers an opinion
dated the Closing Date and in substantially the form attached
hereto as Schedule B . This item shall be applicable for all
Subsequent Closings as well.
(g) Security Agreement . The
Investors shall have received, each executed and delivered by the
Borrowers and the Investors (or any Collateral Agent on their
behalf) a security agreement in the form attached hereto as
Exhibit C (the “Security Agreement”) under which
each Borrower grants to the Collateral Agent (as defined in
Section 7.1(a) hereto), as agent for the Investors, a security
interest in the Collateral.
(h) [RESERVED]
(i) Resolutions, etc . The
Investors shall have received (i) a certificate, dated the
Closing Date, of an authorized signatory of each Borrower as of the
date of the Initial Closing certifying (A) copies of the
resolutions and other actions taken or adopted by the Borrowers
authorizing the execution, delivery and performance of the
Transaction Documents (as defined below) to which the Borrower is a
party, and (B) the Organic Documents (as defined in the Note)
of the Borrowers (which shall also be certified by the Secretary of
State (or other appropriate Governmental Authority) of the state in
which the Borrower is organized or formed (to the extent
available)), (ii) a good standing certificate with respect to
the Borrowers as of a date within 5 days of the Initial Closing
from the Secretary of the State (or other appropriate Governmental
Authority) of the state in which the Borrower is organized or
formed, and (iii) evidence of qualification of the Borrowers
to do business in California. As used herein, the
“Transaction Documents” means this Agreement, the
Collateral Documents, the Notes, the Warrants and any other and all
other certificates, documents, agreements and instruments delivered
to the Investors under or in connection with this
Agreement.
3
(j) Collateral Matters . The
Borrowers shall have delivered to the Investors (or any Collateral
Agent on their behalf) confirmation that all UCC-1 financing
statements and other filings necessary or appropriate to perfect
the security interests of the Investors (or any Collateral Agent on
their behalf) in the Collateral have been accepted for filing. As
used herein, the “Collateral Documents” means,
collectively, the Security Agreement and any other agreement
pursuant to which the Borrowers or any other Person provides a Lien
on its assets in favor of the Investors (or any Collateral Agent on
their behalf), and all filings, documents and agreements made or
delivered pursuant thereto.
2.4 Delivery . At each
Closing (i) each Investor participating in such Closing shall
deliver a check or wire transfer of immediately available funds in
the amount of such Investor’s Principal Amount of Notes
purchased with respect to such Closing payable to the escrow
account as follows: Signature Bank, as escrow agent to Cardium
Therapeutics, Inc., ABA Number : 026013576, Account
Number : 1501162406 and (ii) the Borrowers shall execute
and deliver to each such Investor a Note reflecting the name of the
Investor, a Principal Amount equal to such Investor’s
principal amount and the date of such Closing, and the Company
shall execute and deliver to each such Investor a Warrant as
contemplated by Section 1.2 . Each such Note shall be a
binding obligation of the Borrowers upon execution thereof by the
Borrowers and delivery thereof to an Investor. Each such Warrant
shall be a binding obligation of the Company upon execution thereof
by the Company and delivery thereof to an Investor.
SECTION 3
REPRESENTATIONS AND WARRANTIES OF
INVESTORS
Each Investor hereby severally
represents, warrants and covenants to the Borrowers as
follows:
3.1 Purchase for Own Account
. Such Investor is acquiring the Notes, the Warrants and the Common
Stock issuable upon exercise of the Warrants (collectively, the
“Securities”) solely for investment for such
Investor’s own account not as a nominee or agent, and not
with a view to the resale or distribution of any part thereof, and
such Investor has no present intention of selling, granting any
participation in, or otherwise distributing the same. The
acquisition by such Investor of any of the Securities shall
constitute confirmation of the representation by such Investor that
such Investor does not have any contract, undertaking, agreement or
arrangement with any person to sell, transfer or grant
participations to such person or to any third person, with respect
to any of the Securities.
3.2 Disclosure of Information
. Such Investor has (i) received all the information it
considers necessary or appropriate for deciding whether to acquire
the Securities, and (ii) reviewed the documents filed by the
Company under the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), from the end of its most recently
completed fiscal year through the date hereof including, without
limitation, its most recent reports on Form 10-K and Form 10-Q
(together with all exhibits thereto) which are available for
viewing on the SEC’s EDGAR website located at
http://www.sec.gov or were furnished by the Company
upon request. Such Investor further represents that it has had an
opportunity to ask questions and receive answers from the Borrowers
regarding the terms and conditions of the offering of the
Securities and the business, properties, prospects and financial
condition of the Borrowers.
4
3.3 Investment Experience .
Either (i) such Investor or its officers, directors, managers
or controlling persons has a preexisting personal or business
relationship with the Company or its officers, directors or
controlling persons or with Empire Asset Management Company
(sometimes referred to herein as the “Placement
Agent”), or (ii) such Investor, by reason of its own
business and financial experience, has the capacity to protect its
own interests in connection with the investment contemplated
hereby. Such Investor represents that it is an investor in
securities of companies in the development stage and acknowledges
that it is able to fend for itself, can bear the economic risk of
its investment, and has such knowledge and experience in financial
or business matters that it is capable of evaluating the merits and
risks of the investment in the Securities. Such Investor
acknowledges that any investment in the Securities involves a high
degree of risk, and represents that it is able, without materially
impairing its financial condition, to hold the Securities for an
indefinite period of time and to suffer a complete loss of its
investment. Such Investor further represents that it has reviewed
the Risk Factors which are attached to this Agreement as Exhibit
D hereto.
3.4 Accredited Investor .
Such Investor represents that it is an “accredited
investor” within the meaning of Securities and Exchange
Commission (“SEC”) Rule 501 of Regulation D, as
presently in effect and, for the purpose of
Section 25102(f) of the California Corporations Code, he
or she is excluded from the count of “purchasers”
pursuant to Rule 260.102.13 thereunder.
3.5 Restrictions on Transfer
. Such Investor understands that the Securities are characterized
as “restricted securities” under the federal securities
laws inasmuch as they are being acquired from the Borrowers in a
transaction not involving a public offering and that under such
laws and applicable regulations such securities may be resold
without registration under the Securities Act of 1933, as amended
(the “Act”), only in certain limited circumstances. In
this connection, such Investor represents that it is familiar with
SEC Rule 144, as presently in effect, and understands the resale
limitations imposed thereby and by the Act. SUCH INVESTOR
UNDERSTANDS AND ACKNOWLEDGES HEREIN THAT AN INVESTMENT IN THE
COMPANY’S SECURITIES INVOLVES AN EXTREMELY HIGH DEGREE OF
RISK AND MAY RESULT IN A COMPLETE LOSS OF HIS, HER OR ITS
INVESTMENT. Such Investor understands that the Securities have not
been and will not be registered under the Act and have not been and
will not be registered or qualified in any state in which they are
offered, and thus the Investor will not be able to resell or
otherwise transfer his, her or its Securities unless they are
registered under the Act and registered or qualified under
applicable state securities laws, or an exemption from such
registration or qualification is available. Such Investor has no
immediate need for liquidity in connection with this investment and
does not anticipate that it will need to sell his, her or its
Securities in the foreseeable future.
3.6 Further Limitations on
Disposition . Without in any way limiting the representations
set forth above, such Investor further agrees not to make any
disposition of all or any portion of the Securities unless and
until the transferee has agreed in writing for the benefit of the
Company to be bound by this Section 3 and any other
agreement which the holders of Common Stock are required to execute
and deliver, and:
(a) there is then in effect a
registration statement under the Act covering such proposed
disposition and such disposition is made in accordance with such
registration statement; or
5
(b) (i) such Investor shall
have notified the Company of the proposed disposition and shall
have furnished the Company with a detailed statement of the
circumstances surrounding the proposed disposition, and
(ii) if reasonably requested by the Company, such Investor
shall have furnished the Company with an opinion of counsel
reasonably satisfactory to the Company that such disposition will
not require registration of such shares under the Act. It is agreed
that the Company will not require opinions of counsel for
transactions made pursuant to Rule 144 except in unusual
circumstances.
(c) Notwithstanding the provisions
of subsections (a) and (b) above, no such registration
statement or opinion of counsel shall be necessary for a transfer
by an Investor that is a partnership or limited liability company
to a partner of such partnership or a member of such limited
liability company or a retired partner of such partnership who
retires after the date hereof or a retired member of such limited
liability company who retires after the date hereof, or to the
estate of any such partner, retired partner, member or retired
member or the transfer by gift, will or intestate succession by any
partner or member to his or her spouse or to the siblings, lineal
descendants or ancestors of such partner or member or his or her
spouse, if the transferee agrees in writing to be subject to the
terms hereof to the same extent as if he or she were an original
Investor hereunder.
3.7 Certain Trading
Activities . Other than with respect to this Agreement and the
purchase or sales contemplated herein, since the time that such
Investor was first contacted by the Company or the Placement Agent,
neither such Investor nor any Affiliate (as defined by Rule 405
promulgated pursuant to the Act) of such Investor which
(x) had knowledge of the transactions contemplated hereby,
(y) has or shares discretion relating to such Investor’s
investments and trading or information concerning such
Investor’s investments and (z) is subject to such
Investor’s review or input concerning such Affiliate’s
investments or trading (collectively, “Trading
Affiliates”) has directly or indirectly, nor has any Person
acting on behalf of or pursuant to any understanding with such
Investor or Trading Affiliate, effected or agreed to effect any
purchases or sales of securities of the Company. Such Investor
hereby covenants and agrees not to, and shall cause its Trading
Affiliates not to, engage, directly or indirectly, in any purchases
or sales of securities of the Company during the period from the
date hereof until such time as the transactions contemplated by
this Agreement are first publicly announced.
3.8 Brokers and Finders . No
Investor will have, as a result of the transactions contemplated by
the Transaction Documents, any valid right, interest or claim
against or upon the Borrowers or any other Investor for any
commission, fee or other compensation pursuant to any agreement,
arrangement or understanding entered into by or on behalf of such
Investor. Investor acknowledges the fees payable by the Company to
Empire Asset Management Company in connection with the transactions
contemplated herein as described in Section 8.16.
6
SECTION 4
REPRESENTATIONS AND WARRANTIES OF
THE BORROWERS
Each Borrower hereby jointly and
severally represents, warrants and covenants to each Investor
that:
4.1 Organization, Good Standing
and Qualification; Licenses . Each Borrower is duly organized,
validly existing and in good standing under the laws of the State
of Delaware and has all requisite power and authority to own and
hold under lease its property and to carry on its business as
currently conducted (and further with respect to the Company as
described in the documents filed by the Company under the Exchange
Act), except where the failure to hold any such licenses, permits,
registrations and other approvals would not reasonably be expected
to have a Material Adverse Effect (as defined in the Note). Each of
the Borrowers is qualified to do business and is in good standing
in the State of California and in each jurisdiction in which it
conducts business other than such jurisdictions where the failure
to be so qualified would not reasonably be expected to have a
Material Adverse Effect.
4.2 Authorization . Each of
the Borrowers have taken all action necessary for the
authorization, execution and delivery of this Agreement, the
performance of their respective obligations hereunder, and the
authorization, issuance (or reservation for issuance), sale and
delivery of the Securities. Each of the Transaction Documents to
which the Borrower is a party constitutes the valid and legally
binding obligation of the Borrower, enforceable against the
Borrower in accordance with its terms, except (i) as limited
by applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of
creditors’ rights generally, and (ii) as limited by laws
relating to the availability of specific performance, injunctive
relief or other equitable remedies.
4.3 Capitalization . The
capitalization of the Company is as set forth on Schedule
4.3 as of the date specified therein. The Company has not
issued any capital stock since its most recently filed periodic
report under the Exchange Act, other than pursuant to the exercise
of employee stock options under the Company’s stock option
plans, the issuance of shares of Common Stock to employees pursuant
to the Company’s employee stock purchase plans and pursuant
to the conversion or exercise of Common Stock Equivalents
outstanding as of the date of the most recently filed periodic
report under the Exchange Act. Except as disclosed in the SEC
Reports, no Person has any right of first refusal, preemptive
right, right of participation, or any similar right to participate
in the transactions contemplated by the Transaction Documents.
Except as a result of the purchase and sale of the Securities or as
disclosed in the SEC Reports, there are no outstanding options,
warrants, scrip rights to subscribe to, calls or commitments of any
character whatsoever relating to, or securities, rights or
obligations convertible into or exercisable or exchangeable for, or
giving any Person any right to subscribe for or acquire, any shares
of Common Stock, or contracts, commitments, understandings or
arrangements by which the Company or any Subsidiary is or may
become bound to issue additional shares of Common Stock or Common
Stock Equivalents. Except as set forth on Schedule 4.3
attached hereto or as disclosed in the SEC Reports, the issuance
and sale of the Securities will not obligate the Company to issue
shares of Common Stock or other securities to any Person (other
than the Investors) and will not result in a right of any holder of
Company securities to adjust the exercise, conversion, exchange or
reset price under any of such securities.
7
All of the outstanding shares of capital stock
of the Company are validly issued, fully paid and nonassessable,
have been issued in compliance with all federal and state
securities laws, and none of such outstanding shares was issued in
violation of any preemptive rights or similar rights to subscribe
for or purchase securities. No further approval or authorization of
any stockholder, the Board of Directors or others is required for
the issuance and sale of the Securities. There are no stockholders
agreements, voting agreements or other similar agreements with
respect to the Company’s capital stock to which the Company
is a party or, to the knowledge of the Company, between or among
any of the Company’s stockholders. The Company owns, directly
or indirectly, all of the capital stock or other equity interests
of each of Innercool and TRC free and clear of any Liens, and all
of the issued and outstanding shares of capital stock of each of
Innercool and TRC are validly issued and are fully paid,
non-assessable and free of preemptive and similar rights to
subscribe for or purchase securities.
4.4 Litigation . Except as
described in the reports filed by the Company pursuant to the
Exchange Act, there is no action, suit, proceeding or investigation
pending or, to the knowledge of the Borrower, currently threatened
against the Borrower that questions the validity of this Agreement,
the right of the Borrower to enter into this Agreement, or to
consummate the transactions contemplated hereby, or that has or
could reasonably be expected to result, either individually or in
the aggregate, in any Material Adverse Effect. Except as disclosed
in the SEC Reports, there is no action, suit, proceeding or
investigation by any Borrower currently pending or which any
Borrower intends to initiate.
4.5 Absence of Required Consents;
No Violations . No consent, approval, order or authorization
of, or registration, qualification, designation, declaration or
filing with, any Governmental Authority is required in connection
with the execution, delivery and performance by, or enforcement
against, any Borrower of the Transaction Documents, except for such
filing(s) pursuant to applicable state securities laws as may be
necessary, which filings will be timely effected after the relevant
Closing, and except for recordings or filings in connection with
the perfection of the Liens on the Collateral in favor of the
Investors (or any Collateral Agent of their behalf). No Borrower is
in violation or default (i) of any provision of its Organic
Documents, or (ii) of any instrument, judgment, order, writ,
decree or contract to which it is a party or by which it is bound,
or, to the best of its knowledge, of any provision of any federal
or state statute, rule or regulation which is, to the best of its
knowledge, applicable to the Borrower, except in the case of this
clause (ii) for such violations or defaults which do not, or
could not reasonably be expected to result in a Material Adverse
Effect. As of the Initial Closing, the execution, delivery and
performance of the Transaction Documents and the consummation of
the transactions contemplated thereby will not, result in any such
violation or be in conflict with or constitute, with or without the
passage of time and giving of notice, either a default under any
such provision, instrument, judgment, order, writ, decree or
contract or an event that results in the creation of any Lien upon
any material assets of any Borrower or the suspension, revocation,
impairment, forfeiture or nonrenewal of any material permit,
license, authorization or approval applicable to any Borrower, its
business or operations or any of its assets or properties, except
for such results which could not reasonably be expected to result
in a Material Adverse Effect.
8
4.6 Offering . Subject in
part to the truth and accuracy of each Investor’s
representations set forth in Section 3 of this
Agreement, the offer, sale and issuance of the Notes and Warrants
as contemplated by this Agreement are exempt from the registration
requirements of the Act and will not result in a violation of the
qualification or registration requirements of the any applicable
state securities laws.
4.7 Valid Issuance of Common
Stock . The shares of Common Stock issuable upon exercise of
the Warrants, when issued, sold and delivered in accordance with
the terms of the Warrants for the consideration expressed therein,
will be duly and validly issued, fully paid, and nonassessable, and
will be free of restrictions on transfer other than restrictions on
transfer under this Agreement.
4.8 SEC Reports . The Company
has filed all reports, schedules, forms, statements and other
documents required to be filed by the Company under the Act and the
Exchange Act, including pursuant to Section 13(a) or 15(d)
thereof, for the two years preceding the date hereof (or such
shorter period as the Company was required by law or regulation to
file such material) (the foregoing materials, including the
exhibits thereto and documents incorporated by reference therein,
being collectively referred to herein as the “SEC
Reports”) on a timely basis or has received a valid extension
of such time of filing and has filed any such SEC Reports prior to
the expiration of any such extension. As of their respective dates,
the SEC Reports complied in all material respects with the
requirements of the Act and the Exchange Act, as applicable, and
none of the SEC Reports, when filed, contained any untrue statement
of a material fact or omitted to state a material fact required to
be stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were
made, not misleading. The financial statements of the Company
included in the SEC Reports comply in all material respects with
applicable accounting requirements and the rules and regulations of
the SEC with respect thereto as in effect at the time of filing.
Such financial statements have been prepared in accordance with
United States generally accepted accounting principles applied on a
consistent basis during the periods involved (“GAAP”),
except as may be otherwise specified in such financial statements
or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present
in all material respects the financial position of the Company and
its consolidated subsidiaries as of and for the dates thereof and
the results of operations and cash flows for the periods then
ended, subject, in the case of unaudited statements, to normal,
immaterial, year-end audit adjustments.
4.9 Use of Proceeds . The
proceeds of from the sale of the Notes shall be used only for
general working capital purposes. Each of the Borrowers
acknowledges that it will benefit directly and indirectly from the
loan advanced to the Borrowers.
4.10 Collateral . Borrowers
are, and will remain, the sole and lawful owners, and in possession
of, the Collateral, other than (a) inventory sold in the
ordinary course of business (b) Collateral which is licensed
by or to any Borrower and (c) assets maintained with third
parties in the ordinary course of business. Borrowers have the sole
right and lawful authority to grant the security interest described
in this Agreement. The Collateral is, and will remain, free and
clear of all Liens (other than Permitted Liens). All facilities,
machinery, equipment, fixtures, vehicles and other properties
owned, leased or used by the Borrowers are in good operating
condition and repair and are reasonably fit and usable for the
purposes for which they are being used. Borrowers are in compliance
with all material terms of each lease to which it is a party or is
otherwise bound except where such failure to be in compliance,
either individually or in the aggregate has not had, or could not
reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect.
9
4.11 Compliance with Laws .
Each Borrower is and will remain in compliance in all material
respects with all laws, statutes, ordinances, rules and regulations
applicable to it including, without limitation, (i) ensuring
that no person who owns a controlling interest in or otherwise
controls any Borrower is or shall be (a) listed on the
Specially Designated Nationals and Blocked Person List maintained
by the Office of Foreign Assets Control (“OFAC”),
Department of Treasury, and/or any other similar lists maintained
by OFAC pursuant to any authorizing statute, Executive Order or
regulation or (b) a person designated under Section 1(b),
(c) or (d) of Executive Order No. 13224 (September
23, 2001), any related enabling legislation or any other similar
Executive Orders, and (ii) compliance with all applicable Bank
Secrecy Act (“BSA”) laws, regulations and government
guidance on BSA compliance and on the prevention and detection of
money laundering violations. Each Borrower shall be in compliance
with the minimum funding requirements of the Employee Retirement
Income Security Act of l974, as amended from time to time
(“ERISA”) with respect to any employee benefit plans
subject to ERISA except to the extent that any such failure to
comply does not, or could not, in the aggregate, reasonably be
expected to result in a material adverse effect on the
Borrowers’ business or financial condition, taken as a whole.
No Borrower is an “investment company” or a company
“controlled” by an “investment company”
within the meaning of the Investment Company Act of 1940, and no
Borrower is not engaged principally, or as one of its important
activities, in the business of extending credit for the purpose of
purchasing or carrying margin stock (within the meaning of
Regulations T, U and X of the Board of Governors of the Federal
Reserve System). Each Borrower has all material franchises,
permits, licenses and any similar authority necessary for the
conduct of its business as now being conducted by it, the lack of
which could, either individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect.
4.12 Intellectual Property.
The Borrowers have, or have rights to use, all patents, patent
applications, trademarks, trademark applications, service marks,
trade names, trade secrets, inventions, copyrights, licenses and
other intellectual property rights and similar rights necessary or
material for use in connection with their respective businesses as
described in the SEC Reports and which the failure to so has, or
could have a Material Adverse Effect (collectively, the
“Intellectual Property Rights”). None of the Borrowers
have received a notice (written or otherwise) that any of the
Intellectual Property Rights used by any Borrower violates or
infringes upon the rights of any Person, nor do they have any
reason to believe there is a basis for any such claim. All such
Intellectual Property Rights are enforceable, and to the knowledge
of each Borrower there is no existing infringement by another
Person of any of the Intellectual Property Rights. Borrowers do not
believe it is or will be necessary to utilize any inventions, trade
secrets or proprietary information of any of its employees made
prior to their employment by Borrowers, except for inventions,
trade secrets or proprietary information that have been rightfully
assigned to Borrowers. Except as disclosed in the SEC Reports,
there are no outstanding options, licenses or agreements of any
kind relating to the Intellectual Property Rights, nor are the
Borrowers bound by or a party to any options, licenses or
agreements of any kind with respect to the patents, trademarks,
service marks, trade names, copyrights, trade secrets, licenses,
information and other proprietary rights and processes of any other
person or entity other than such licenses or agreements arising
from the purchase of “off the shelf” or standard
products. The Borrowers have taken reasonable security measures to
protect the secrecy, confidentiality and value of all of their
intellectual properties, except where failure to do so does not or
could not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect.
10
4.13 Liabilities . No
Borrower has any material contingent liabilities, except current
liabilities incurred in the ordinary course of business and
liabilities disclosed in the SEC Reports.
4.14 Employees . No Borrower
has any collective bargaining agreements with any of its employees.
There is no labor union organizing activity pending or, to each
Borrower’s knowledge, threatened with respect to any
Borrower. Except as disclosed in the SEC Reports, no Borrower is a
party to or bound by any currently effective employment contract,
deferred compensation arrangement, bonus plan, incentive plan,
profit sharing plan, retirement agreement or other employee
compensation plan or agreement. To each Borrower’s knowledge,
no employee any Borrower, nor any consultant with whom a Borrower
has contracted, is in violation of any term of any employment
contract, proprietary information agreement or any other agreement
relating to the right of any such individual to be employed by, or
to contract with, a Borrower because of the nature of the business
to be conducted by the borrower; and to each Borrower’s
knowledge the continued employment by the Borrower of their present
employees, and the performance of Borrowers’ contracts with
its independent contractors, will not result in any such violation.
No Borrower is aware that any of its employees is obligated under
any contract (including licenses, covenants or commitments of any
nature) or other agreement, or subject to any judgment, decree or
order of any court or administrative agency, that would interfere
with their duties to the Borrowers. No Borrower has received any
notice alleging that any such violation has occurred. Except for
employees who have a current effective employment agreement with a
Borrower, no employee of the Borrowers has been granted the right
to continued employment or to any material compensation following
termination of employment with a Borrower. The Borrowers are not
aware that any officer, key employee or group of employees intends
to terminate his, her or their employment with any Borrower, nor
does any Borrower have a present intention to terminate the
employment of any officer, key employee or group of
employees.
4.15. Obligations to Related
Parties . Except as disclosed in the SEC Documents, no Borrower
has any obligation to its officers, directors, stockholders or
employees other than:
(a) for payment of salary for
services rendered and for bonus payments;
(b) reimbursement for reasonable
expenses incurred on behalf of the Borrower;
(c) for other standard employee
benefits made generally available to all employees (including stock
option agreements outstanding under any stock option plan approved
by the Board of Directors of the Company); and
(d) obligations disclosed in any of
its SEC Reports.
Except as disclosed in the SEC
Documents, none of the officers, directors or, to the best of the
Borrower’s knowledge, key employees or stockholders of the
Company or any members of their immediate families, are indebted to
a Borrower, individually or in the aggregate, in excess of $50,000
or have any direct or indirect ownership interest in any firm or
corporation with which a
11
Borrower is affiliated or with which its has a
business relationship, or any firm or corporation which competes
with the Borrower, other than passive investments in publicly
traded companies (representing less than one percent (1%) of
such company) which may compete with the Borrower. Except as
described above, no officer, director or stockholder, or any member
of their immediate families, is, directly or indirectly, interested
in any material contract with the Borrower and no agreements,
understandings or proposed transactions are contemplated between
the Borrower and any such person. No Borrower is a guarantor or
indemnitor of any indebtedness of any other person, firm or
corporation.
4.16 Recent Events . Since
December 31, 2007, except as disclosed in any SEC Report,
there has not been:
(a) any change in the business,
assets, liabilities, condition (financial or otherwise),
properties, operations or prospects of any Borrower, which
individually or in the aggregate has had, or could reasonably be
expected to have, individually or in the aggregate, a Material
Adverse Effect;
(b) any resignation or termination
of any officer, key employee or group of employees of any
Borrower;
(c) any material change, except in
the ordinary course of business, in the contingent obligations of
any Borrower by way of guaranty, endorsement, indemnity, warranty
or otherwise;
(d) any damage, destruction or loss,
whether or not covered by insurance, has had, or could reasonably
be expected to have, individually or in the aggregate, a Material
Adverse Effect;
(e) any waiver by any Borrower of a
valuable right or of a material debt owed to it;
(f) any direct or indirect loans
made by any Borrower to any stockholder, employee, officer or
director of any Borrower, other than advances made in the ordinary
course of business;
(g) any material change in any
compensation arrangement or agreement with any employee, officer,
director or stockholder of any Borrower;
(h) any declaration or payment of
any dividend or other distribution of the assets of any
Borrower;
(i) any labor organization activity
related to any Borrower;
(j) any debt, obligation or
liability incurred, assumed or guaranteed by any Borrower, except
those for immaterial amounts and for current liabilities incurred
in the ordinary course of business;
(k) any sale, assignment or transfer
of any patents, trademarks, copyrights, trade secrets or other
intangible assets owned by any Borrower;
12
(l) any change in any material
agreement to which any Borrower is a party or by which it is bound
which either individually or in the aggregate has had, or could
reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect;
(m) any other event or condition of
any character that, either individually or in the aggregate, has
had, or could reasonably be expected to have, individually or in
the aggregate, a Material Adverse Effect; or
(n) any arrangement or commitment by
any Borrower to do any of the acts described in subsection
(a) through (m) above.
4.17 No Brokers . Except as
set forth in Section 8.16, the Borrowers have taken no action
which would give rise to any claim by any person for brokerage
commissions, transaction fees or similar payments relating to this
Agreement or the transactions contemplated hereby.
4.18. Registration Rights and
Voting Rights . Except as disclosed in the SEC Reports, and
except as contemplated by this Agreement, no Borrower is presently
under any obligation, and has not granted any rights, to register
any of t